(ARGX) argenx - Performance 21.3% in 12m
ARGX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
70.66%
#4 in Peer-Group
Rel. Strength
67.48%
#2497 in Stock-Universe
Total Return 12m
21.34%
#46 in Peer-Group
Total Return 5y
123.36%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 33.1 |
| P/E Forward | 55.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 671.75 USD |
| 52 Week Low | 461.01 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 45.94 |
| Buy/Sell Signal +-5 | 0.60 |
| Support / Resistance | Levels |
|---|---|
| Support | 548.6, 520.2, 381.3 |
| Resistance | 640.1, 601.6, 567.5 |
12m Total Return: ARGX (21.3%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
| Total Return (including Dividends) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.56% | 3.15% | 4.01% |
| 3 Months | -3.56% | 17.08% | 17.14% |
| 12 Months | 21.34% | -11.14% | 13.46% |
| 5 Years | 123.36% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -17.2% | 52.1% | 90.3% |
| 3 Months | -66.8% | 79.4% | 97.5% |
| 12 Months | 45.8% | -87.4% | 46.4% |
| 5 Years | 91.9% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th43.00 | -5.54% | -6.32% |
| 3 Month | %th21.00 | -17.63% | -17.68% |
| 12 Month | %th77.00 | 36.55% | 6.94% |
| 5 Years | %th96.00 | 186.21% | 5.00% |
FAQs
Does argenx (ARGX) outperform the market?
Yes,
over the last 12 months ARGX made 21.34%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ARGX made -3.56%, while XBI made 17.08%.
Performance Comparison ARGX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARGX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.1% | -6.6% | -24.3% | 8% |
| US NASDAQ 100 | QQQ | 2.2% | -6.8% | -26.3% | 8% |
| German DAX 40 | DAX | 1.8% | -3.8% | -36.5% | -9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.9% | -7.1% | -28.8% | 3% |
| Hongkong Hang Seng | HSI | 1.2% | -5.4% | -46.3% | -14% |
| India NIFTY 50 | INDA | 3.5% | -1.8% | -24.8% | 24% |
| Brasil Bovespa | EWZ | 6.3% | -1.9% | -39.4% | 20% |
ARGX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.5% | -4.3% | -27.6% | -2% |
| Consumer Discretionary | XLY | 1.2% | -5.9% | -16.6% | 3% |
| Consumer Staples | XLP | 4.2% | -2.4% | -23.4% | 14% |
| Energy | XLE | -0.8% | -6.7% | -16.8% | 19% |
| Financial | XLF | 3.6% | -5.2% | -26.7% | -4% |
| Health Care | XLV | 2% | -2.6% | -12.8% | 28% |
| Industrial | XLI | 1.7% | -7% | -30.2% | -2% |
| Materials | XLB | 1.5% | -7% | -25% | 17% |
| Real Estate | XLRE | 2.4% | -2.4% | -22.8% | 13% |
| Technology | XLK | 2.2% | -9.2% | -29.4% | 10% |
| Utilities | XLU | 2.1% | -5.2% | -28.4% | 1% |
| Aerospace & Defense | XAR | 1.5% | -9.4% | -44.3% | -28% |
| Biotech | XBI | -1.5% | -5.7% | -14.1% | 32% |
| Homebuilder | XHB | -0.9% | -11.3% | -17.8% | 22% |
| Retail | XRT | 2.2% | -5.8% | -19.5% | 15% |
ARGX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.5% | -5.86% | -10.4% | 26% |
| Natural Gas | UNG | 3.9% | 3.9% | 1.7% | 23% |
| Gold | GLD | 2% | -2.8% | -42.2% | -17% |
| Silver | SLV | -2.2% | -8.9% | -46.4% | -1% |
| Copper | CPER | -8.2% | -17.5% | -43.9% | -2% |
ARGX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3% | -2.5% | -19% | 26% |
| iShares High Yield Corp. Bond | HYG | 2.7% | -3.7% | -21.3% | 12% |